Evidence map›Paper›PMID 42861158›Full record

ArticleQuantitative imaging in medicine and surgery2026

Utilization of

Yiqiao Luo, Xiao Zhong, Huaju Yang, Jiayi Lv, Jia Luo, Lijiao Pei, Xin Zhang, Huijun Zhou, Minggang Su, Xingchen Peng

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yiqiao LuoDepartment of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.ORCID https://orcid.org/0000-0002-0219-1934
Xiao ZhongDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Huaju YangDepartment of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Jiayi LvRadiotherapy Physics & Technology Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Jia LuoRadiophysical Technology Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Lijiao PeiLaboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
Xin ZhangDepartment of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Huijun ZhouDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Minggang SuDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xingchen PengDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate delineation of the nasopharynx gross tumor volume (GTVnx) of nasopharyngeal carcinoma (NPC) is crucial for patients requiring radiotherapy, as it correlates with prognosis. Current GTVnx delineation methods have significant shortcomings, often resulting in insufficient coverage of the radiotherapy target area. Gallium-68-labeled fibroblast activation protein inhibitor ( Methods: This prospective study enrolled 19 patients with NPC who underwent Results: Nineteen pathologically confirmed NPC patients [mean age, 48.84±12.12 years (range, 24-70 years); 12 men (63.16%)] were enrolled. All included NPC patients demonstrated high Conclusions: The combined use of

Indexed as

gallium-68-labeled fibroblast activation protein inhibitor (68Ga-FAPI)Nasopharyngeal carcinoma (NPC)nasopharynx gross tumor volume (GTVnx)organs at risk protection (OAR protection)positron emission tomography/computed tomography (PET/CT)

Identifiers

PMID42861158
PMCPMC13654112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.